Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.

PMID: 33289433
Journal: Future Oncology
Year: 2021
Reference: Future Oncol. 2021 Apr;17(10):1209-1218. doi: 10.2217/fon-2020-1100. Epub 2020 Dec 8.
Impact factor: 3.404
Publication type: Review in international publication
Authors: Peiro, Gloria, Peg, Vicente, Lopez-Garcia, Maria Angeles, Comerma, Laura, Suarez-Gauthier, Ana, Ruiz, Irune, Rojo, Federico, Lopez, Angel Concha, Garcia-Caballero, Tomas et al.
DOI: 10.2217/fon-2020-1100

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.

PMID: 33289433
Journal: Future Oncology
Year: 2021
Reference: Future Oncol. 2021 Apr;17(10):1209-1218. doi: 10.2217/fon-2020-1100. Epub 2020 Dec 8.
Impact factor:
Publication type: Review in international publication
Authors: Comerma, Laura; Garcia-Caballero, Tomas; Lopez, Angel Concha; Lopez-Garcia, Maria Angeles; Peg, Vicente; Peiro, Gloria; Rojo, Federico; Ruiz, Irune; Suarez-Gauthier, Ana et al.
DOI: 10.2217/fon-2020-1100

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

PMID: 34051178
Journal: LANCET ONCOLOGY
Year: 2021
Reference: Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26.
Impact factor: 41.316
Publication type: Paper in international publication
Authors: Ladoire, Sylvain, Powles, Thomas, Csoszi, Tibor, Ozguroglu, Mustafa, Matsubara, Nobuaki, Geczi, Lajos, Cheng, Susanna Y-S, Fradet, Yves, Oudard, Stephane, Rapatoni, Liane et al.
DOI: 10.1016/S1470-2045(21)00152-2

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

PMID: 34051178
Journal: LANCET ONCOLOGY
Year: 2021
Reference: Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26.
Impact factor:
Publication type: Paper in international publication
Authors: Aarts, Maureen; Abali, Huseyin; Abdelsalam, Mahmoud; Ades, Steven; Alekseev, Boris Yakovlevich; Alekseev, Sergey M; Almeida Silva, Jamile; Alonso Gordoa, Teresa; Alva, Ajjai; Alva, Ajjai et al.
DOI: 10.1016/S1470-2045(21)00152-2

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 Study): an open-label, nonrandomized, multicenter, phase 2 trial.

PMID: 34293460
Journal: ANNALS OF ONCOLOGY
Year: 2021
Reference: Ann Oncol. 2021 Oct;32(10):1276-1285. doi: 10.1016/j.annonc.2021.07.008. Epub 2021 Jul 20.
Impact factor: 32.976
Publication type: Paper in international publication
Authors: Hughes, B G M, Munoz-Couselo, E, Mortier, L, Bratland, A, Gutzmer, R, Roshdy, O, Mendoza, R Gonzalez, Schachter, J, Arance, A, Grange, F et al.
DOI: 10.1016/j.annonc.2021.07.008

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 Study): an open-label, nonrandomized, multicenter, phase 2 trial.

PMID: 34293460
Journal: ANNALS OF ONCOLOGY
Year: 2021
Reference: Ann Oncol. 2021 Oct;32(10):1276-1285. doi: 10.1016/j.annonc.2021.07.008. Epub 2021 Jul 20.
Impact factor:
Publication type: Paper in international publication
Authors: Arance, A; Billan, S; Bratland, A; Grange, F; Grob, J-J; Gumuscu, B; Gutzmer, R; Hughes, B G M; Joshi, A; Mendoza, R Gonzalez et al.
DOI: 10.1016/j.annonc.2021.07.008

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

PMID: 34086039
Journal: JAMA Oncology
Year: 2021
Reference: JAMA Oncol. 2021 Jun 4. pii: 2780855. doi: 10.1001/jamaoncol.2021.2301.
Impact factor: 31.777
Publication type: Paper in international publication
Authors: Reck, Martin, Keller, Steven M, Samkari, Ayman, Jabbour, Salma K, Lee, Ki Hyeong, Frost, Nikolaj, Breder, Valeriy, Kowalski, Dariusz M, Pollock, Theodore, Reguart, Noemi et al.
DOI: 10.1001/jamaoncol.2021.2301

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

PMID: 34086039
Journal: JAMA Oncology
Year: 2021
Reference: JAMA Oncol. 2021 Jun 4;7(9):1-9. doi: 10.1001/jamaoncol.2021.2301.
Impact factor:
Publication type: Paper in international publication
Authors: Boolell, Vishal; Breder, Valeriy; Frost, Nikolaj; Houghton, Baerin; Jabbour, Salma K; Keller, Steven M; Komiya, Takefumi; Kowalski, Dariusz M; Lee, Ki Hyeong; Levchenko, Evgeny et al.
DOI: 10.1001/jamaoncol.2021.2301

Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy for Unresectable, Locally Advanced, Stage 3 NSCLC: KEYNOTE-799.

PMID: 34700658
Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Year: 2021
Reference: Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3S):S9-S10. doi: 10.1016/j.ijrobp.2021.07.054.
Impact factor:
Publication type: Paper in international publication
Authors: Alawin, I; Boolell, V; Breder, V; Frost, N; Houghton, B; Jabbour, S K; Keller, S; Komiya, T; Kowalski, D; Lee, K H et al.
DOI: 10.1016/j.ijrobp.2021.07.054

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.

PMID: 33894335
Journal: ANNALS OF ONCOLOGY
Year: 2021
Reference: Ann Oncol. 2021 Jul;32(7):881-895. doi: 10.1016/j.annonc.2021.04.008. Epub 2021 Apr 22.
Impact factor: 32.976
Publication type: Paper in international publication
Authors: Esteban, E, Felip, E, Speranza, G, De Angelis, F, Domine, M, Cheng, S Y, Bischoff, H G, Peled, N, Reck, M, Hui, R et al.
DOI: 10.1016/j.annonc.2021.04.008

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.

PMID: 33894335
Journal: ANNALS OF ONCOLOGY
Year: 2021
Reference: Ann Oncol. 2021 Jul;32(7):881-895. doi: 10.1016/j.annonc.2021.04.008. Epub 2021 Apr 22.
Impact factor:
Publication type: Paper in international publication
Authors: Bischoff, H G; Boyer, M; Cheng, S Y; De Angelis, F; Domine, M; Esteban, E; Felip, E; Gadgeel, S; Garassino, M C; Garon, E B et al.
DOI: 10.1016/j.annonc.2021.04.008

Percutaneous atrioseptostomy for left ventricular unloading in pediatric patients in cardiogenic shock on venoarterial ECMO support.

PMID: 33632636
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2021
Reference: Rev Esp Cardiol. 2021 Aug;74(8):710-712. doi: 10.1016/j.rec.2021.01.010. Epub 2021 Feb 23.
Impact factor: 4.753
Publication type: Letter whit IF
Authors: Dolader, Paola, Betrian Blasco, Pedro, Balcells, Joan, Izquierdo-Blasco, Jaume, Gran, Ferran, Marti Aguasca, Gerard et al.
DOI: 10.1016/j.rec.2021.01.010

Percutaneous atrioseptostomy for left ventricular unloading in pediatric patients in cardiogenic shock on venoarterial ECMO support.

PMID: 33632636
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2021
Reference: Rev Esp Cardiol. 2021 Aug;74(8):710-712. doi: 10.1016/j.rec.2021.01.010. Epub 2021 Feb 23.
Impact factor:
Publication type: Letter whit IF
Authors: Balcells, Joan; Betrian Blasco, Pedro; Dolader, Paola; Gran, Ferran; Izquierdo-Blasco, Jaume; Marti Aguasca, Gerard et al.
DOI: 10.1016/j.rec.2021.01.010

Percutaneous Left Atrial Appendage Occlusion.

PMID: 33242871
Journal: CARDIOLOGY
Year: 2021
Reference: Cardiology. 2021;146(1):116-118. doi: 10.1159/000511659. Epub 2020 Nov 26.
Impact factor: 1.869
Publication type: Letter or abstract
Authors: Sambola, Antonia, Radinovic, Andrea, Mazzone, Patrizio et al.
DOI: 10.1159/000511659

Percutaneous Left Atrial Appendage Occlusion.

PMID: 33242871
Journal: CARDIOLOGY
Year: 2021
Reference: Cardiology. 2021;146(1):116-118. doi: 10.1159/000511659. Epub 2020 Nov 26.
Impact factor:
Publication type: Letter or abstract
Authors: Mazzone, Patrizio; Radinovic, Andrea; Sambola, Antonia et al.
DOI: 10.1159/000511659

Percutaneous tibial nerve stimulation in patients with severe low anterior resection syndrome: randomized clinical trial.

PMID: 33793754
Journal: BRITISH JOURNAL OF SURGERY
Year: 2021
Reference: Br J Surg. 2021 Apr 30;108(4):380-387. doi: 10.1093/bjs/znaa171.
Impact factor: 6.939
Publication type: Paper in international publication
Authors: Talavera, E, Fraccalvieri, D, Alberti, P, Ostiz, F, Frago, R, Blanco, A, Pellino, G, Espin-Basany, E, Jimenez, L M, Marinello, F G et al.
DOI: 10.1093/bjs/znaa171

Percutaneous tibial nerve stimulation in patients with severe low anterior resection syndrome: randomized clinical trial.

PMID: 33793754
Journal: BRITISH JOURNAL OF SURGERY
Year: 2021
Reference: Br J Surg. 2021 Apr 30;108(4):380-387. doi: 10.1093/bjs/znaa171.
Impact factor:
Publication type: Paper in international publication
Authors: Alberti, P; Blanco, A; Espin-Basany, E; Fraccalvieri, D; Frago, R; Jimenez, L M; Marinello, F G; Ostiz, F; Pellino, G; Talavera, E et al.
DOI: 10.1093/bjs/znaa171

Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues.

PMID: 34771584
Journal: Cancers
Year: 2021
Reference: Cancers (Basel). 2021 Oct 29;13(21). pii: cancers13215421. doi: 10.3390/cancers13215421.
Impact factor: 6.639
Publication type: Paper in international publication
Authors: Serna, Garazi, Noguera-Julian, Marc, Alonso, Lidia, Parera, Mariona, Catala-Moll, Francesc, Sanchez, Lidia, Fasani, Roberta, Paredes, Roger, Nuciforo, Paolo, Borgognone, Alessandra et al.
DOI: 10.3390/cancers13215421

Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues.

PMID: 34771584
Journal: Cancers
Year: 2021
Reference: Cancers (Basel). 2021 Oct 29;13(21). pii: cancers13215421. doi: 10.3390/cancers13215421.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Lidia; Borgognone, Alessandra; Catala-Moll, Francesc; Fasani, Roberta; Noguera-Julian, Marc; Nuciforo, Paolo; Paredes, Roger; Parera, Mariona; Sanchez, Lidia; Serna, Garazi et al.
DOI: 10.3390/cancers13215421

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.

PMID: 33670864
Journal: Journal of Fungi
Year: 2021
Reference: J Fungi (Basel). 2021 Feb 28;7(3). pii: jof7030176. doi: 10.3390/jof7030176.
Impact factor: 5.816
Publication type: Review in international publication
Authors: Zuccaro, Valentina, Giacobbe, Daniele R, Cortegiani, Andrea, Karaiskos, Ilias, Mercier, Toine, Tejada, Sofia, Peghin, Maddalena, Grecchi, Cecilia, Rebuffi, Chiara, Asperges, Erika et al.
DOI: 10.3390/jof7030176

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.

PMID: 33670864
Journal: Journal of Fungi
Year: 2021
Reference: J Fungi (Basel). 2021 Feb 28;7(3). pii: jof7030176. doi: 10.3390/jof7030176.
Impact factor:
Publication type: Review in international publication
Authors: Asperges, Erika; Bassetti, Matteo; Cortegiani, Andrea; Giacobbe, Daniele R; Grecchi, Cecilia; Karaiskos, Ilias; Mercier, Toine; Peghin, Maddalena; Rebuffi, Chiara; Scudeller, Luigia et al.
DOI: 10.3390/jof7030176

Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study.

PMID: 34876500
Journal: THORAX
Year: 2021
Reference: Thorax. 2021 Dec 7. pii: thoraxjnl-2021-217592. doi: 10.1136/thoraxjnl-2021-217592.
Impact factor: 9.25
Publication type: Paper in international publication
Authors: Soriano-Arandes, Antonio, Santiago, Begona, Tortola, Teresa, Ruiz-Serrano, Maria Jesus, Korta Murua, Jose Javier, Bustillo-Alonso, Matilde, Garrote-Llanos, Maria Isabel, Rodriguez-Molino, Paula, Piqueras, Ana Isabel, Tagarro, Alfredo et al.
DOI: 10.1136/thoraxjnl-2021-217592

Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).

PMID: 32658963
Journal: RHEUMATOLOGY
Year: 2021
Reference: Rheumatology (Oxford). 2021 Jan 5;60(1):217-223. doi: 10.1093/rheumatology/keaa247.
Impact factor: 7.58
Publication type: Paper in international publication
Authors: Pinilla, Blanca, Fernandez-Codina, Andreu, Feijoo-Masso, Carlos, Toledano-Macias, Maria, de Miguel-Campo, Borja, Fonseca-Aizpuru, Eva, Saez-Comet, Luis, Lopez-Dupla, Miguel, Hernandez-Rodriguez, Jose, Martinez-Valle, Fernando et al.
DOI: 10.1093/rheumatology/keaa247

Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).

PMID: 32658963
Journal: RHEUMATOLOGY
Year: 2021
Reference: Rheumatology (Oxford). 2021 Jan 5;60(1):217-223. doi: 10.1093/rheumatology/keaa247.
Impact factor:
Publication type: Paper in international publication
Authors: Carballo, Iago; de Miguel-Campo, Borja; Feijoo-Masso, Carlos; Fernandez-Codina, Andreu; Fonseca-Aizpuru, Eva; Hernandez-Rodriguez, Jose; Lopez-Dupla, Miguel; Martinez-Valle, Fernando; Pinal-Fernandez, Iago; Pinilla, Blanca et al.
DOI: 10.1093/rheumatology/keaa247

Publications

Publications searcher

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 Study): an open-label, nonrandomized, multicenter, phase 2 trial.

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 Study): an open-label, nonrandomized, multicenter, phase 2 trial.

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy for Unresectable, Locally Advanced, Stage 3 NSCLC: KEYNOTE-799.

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.

Percutaneous atrioseptostomy for left ventricular unloading in pediatric patients in cardiogenic shock on venoarterial ECMO support.

Percutaneous atrioseptostomy for left ventricular unloading in pediatric patients in cardiogenic shock on venoarterial ECMO support.

Percutaneous Left Atrial Appendage Occlusion.

Percutaneous Left Atrial Appendage Occlusion.

Percutaneous tibial nerve stimulation in patients with severe low anterior resection syndrome: randomized clinical trial.

Percutaneous tibial nerve stimulation in patients with severe low anterior resection syndrome: randomized clinical trial.

Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues.

Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues.

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.

Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study.

Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).

Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).

Patronage:

Collaborating:

Accreditations: